Roche’s Alecensa lung cancer trial uses AI to find patients
Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificial intelligence to find patients who can benefit.
When given after surgery to remove…
